BBUD:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - BetaBuilders US Equity UCITS ETF - USD (dist) (USD)

ETF | Others |

Last Closing

USD 46.18

Change

-0.07 (-0.15)%

Market Cap

USD 1.13M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.52 (+0.56%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+0.52 (+0.79%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.75 (+1.36%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.67%)

USD 592.18B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.01 (-0.05%)

USD 592.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+6.00 (+0.30%)

USD 331.07B
0QZK:LSE Coca-Cola Co.

-0.70 (-1.11%)

USD 266.08B
0QZO:LSE 0QZO

-0.50 (-0.50%)

USD 258.54B

ETFs Containing BBUD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.70% 76% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.70% 75% C 70% C-
Trailing 12 Months  
Capital Gain 27.45% 86% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.45% 85% B 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.14% 68% D+ 71% C-
Dividend Return 9.14% 67% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.66% 65% D 78% C+
Risk Adjusted Return 85.76% 92% A 95% A
Market Capitalization 1.13M 5% F 4% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.